Home » Topics » Regulatory » EMA

EMA
RSS

Roche and Oryzon to develop epigenetics-based medicines

April 8, 2014

EMA validates Keryx Biopharmaceuticals' MAA for Zerenex

April 3, 2014

EMA validates MolMed's TK cell/gene therapy submission for conditional approval

March 31, 2014

EMA validates ledipasvir/sofosbuvir MAA and grants accelerated assessment

March 28, 2014

Siltuximab receives positive CHMP opinion supporting approval in multicentric Castleman's disease

March 25, 2014

CHMP recommends approval of empagliflozin for type 2 diabetes

March 25, 2014

Takeda Pharmaceutical receives positive CHMP opinion for Entyvio

March 25, 2014

EMA committee recommends approval of Vynfinit and companion imaging agents

March 24, 2014

CHMP issues positive opinion for simeprevir in chronic HCV infection

March 24, 2014

European CHMP recommends approval of tablet formulation of Noxafil

March 3, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...